SEC Filing 8-K: BIOCRYST PHARMACEUTICALS INC

February 27, 2017 7:40am EST

Source: SEC (Index ) via Sqoop

  • § Results of Operations and Financial Condition;
  • § Regulation FD Disclosure;
  • § Financial Statements and Exhibits;

Exhibits